Hemophilia: acquired modifications of the genetic disorder.
D000614:Aminocaproates / Q000627:therapeutic use; D000906:Antibodies; D000917:Antibody Formation; D001803:Blood Transfusion; D003520:Cyclophosphamide / Q000627:therapeutic use; D004789:Enzyme Activation; D005169:Factor VIII; D005342:Fibrinolysis / Q000187:drug effects; D006467:Hemophilia A / Q000235:genetics* / Q000276:immunology; D007156:Immunologic Memory; D007165:Immunosuppression Therapy; D005082:Physical Exertion; D010956:Plasmapheresis; D010958:Plasminogen
D000614:Aminocaproates; D000906:Antibodies; D003520:Cyclophosphamide; D005169:Factor VIII; D010958:Plasminogen